Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Neurological Research and Practice|December 16, 2020
Severe pneumonia with formation of a pulmonary cavity associated with long-term rituximab therapy in multiple sclerosisCarolin Schwake, Ralf Gold
Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 12, 2023
Inpatient care of neuromyelitis optica spectrum disorder in Germany: Nationwide analysis from 2010 to 2021Daniel Richter, Dirk Bartig, Lars Tönges, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 13, 2024
Neonatal B-Cell Levels and Infant Health in Newborns Potentially Exposed to Anti-CD20 Monoclonal Antibodies During Pregnancy or LactationCarolin Schwake, Julia Steinle, Sandra Thiel, et al.
European Journal of Neurology|November 19, 2025
Longitudinal Brain Atrophy Patterns in Early MOG-Antibody Associated Disease and Relapsing Multiple SclerosisTheodoros Ladopoulos, David Bratek, Carolin Schwake, et al.
Multiple Sclerosis and Related Disorders|January 10, 2026
Therapeutic plasma exchange for MOG antibody-associated disease attacks: a systematic review and meta-analysisRoger Santana de Araujo, Guilherme Diogo Silva, Thiago Trajano, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 11, 2024
Cognitive Impairment, Associated Clinical Factors, and MR Volumetric Measures in Myelin Oligodendrocyte Glycoprotein-IgG-Associated DiseaseAnn-Kathrin Kogel, Theodoros Ladopoulos, Carolin Schwake, et al.
Journal of Neuroinflammation|May 30, 2021
Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?Joachim Havla, Thivya Pakeerathan, Carolin Schwake, et al.
Journal of the Peripheral Nervous System : JPNS|September 6, 2021
Report of a fulminant anti-pan-neurofascin-associated neuropathy responsive to rituximab and bortezomibMiriam Fels, Anna Lena Fisse, Carolin Schwake, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 23, 2026
Immuno-Proteomic Features Associated to Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseGerardina Gallaccio, Anna Müller, Meng Wang, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 7, 2023
Humoral COVID-19 vaccine response in patients with NMOSD/MOGAD during anti-IL-6 receptor therapy compared to other immunotherapiesCarolin Schwake, Thivya Pakeerathan, Ingo Kleiter, et al.
Pageof 3